Videos and Podcasts
Investor Briefing - 8 December 2021
On 8 Dec 2021, Pharmaxis Ltd (ASX: PXS) held a virtual investor briefing with the Company’s chief executive officer Mr Gary Phillips. The event featured a short presentation of the Company’s recent progress and future plans post capital raising followed by a Q&A session from attendees.
Watch recording here.
Pharmaxis receives approval for phase 2 study of its cancer drug in liver cancer
Pharmaxis CEO Gary Phillips speaks to Proactive following the news an Investigational New Drug application for a trial of PXS‐5505 in hepatocellular carcinoma (HCC) patients has been cleared by the FDA. The IND was submitted by the University of Rochester Medical Center following positive pre‐clinical results reported in August.
Watch the interview here
Pharmaxis Quarterly Shareholder Update and Investor Presentation
Watch a recording of the Pharmaxis Ltd September Quarterly Shareholder Update by the chief executive officer Mr Gary Phillips on Thursday 28 October 2021.
Watch recording here.